Summary

Large And Small-scale Bioprocessing Market Summary

The global large and small-scale bioprocessing market size was estimated at USD 80.5 billion in 2024 and is expected to reach USD 228.7 billion by 2033, growing at a CAGR of 11.86% from 2025 to 2033. This substantial growth is primarily driven by the increasing global demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies.

Biopharmaceutical companies invest significantly in flexible manufacturing solutions, such as single-use technologies and modular bioprocessing systems, which help accelerate development timelines and reduce production costs.

Global Large And Small-Scale Bioprocessing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global large and small-scale bioprocessing market on the basis of scale, workflow, product, application, use type, mode, and region:

• Scale Outlook (Revenue, USD Million, 2021 - 2033)
• Industrial Scale (Over 50,000 Litres)
• Small Scale (Less Than 50,000 Litres)
• Workflow Outlook (Revenue, USD Million, 2021 - 2033)
• Downstream Processing
• Fermentation
• Upstream Processing
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Bioreactors/Fermenters
• Cell Culture Products
• Filtration Assemblies
• Bioreactors Accessories
• Bags & Containers
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceuticals
• Speciality Industrial Chemicals
• Environmental Aids
• Use Type Outlook (Revenue, USD Million, 2021 - 2033)
• Multi-Use
• Single-Use
• Mode Outlook (Revenue, USD Million, 2021 - 2033)
• In-house
• Outsourced
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Scale
1.2.2. Workflow
1.2.3. Product
1.2.4. Application
1.2.5. Mode
1.2.6. Use Type
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Large and Small-Scale Bioprocessing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing implementation of single-use technology (SUT) for bioproduction
3.2.1.2. Rising demand for biologics
3.2.2. Market restraint analysis
3.2.2.1. High initial setup and operational costs for large-scale bioprocessing
3.2.2.2. Complexity and regulatory hurdles
3.3. Large and small-scale bioprocessing Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Large and Small-Scale Bioprocessing Market: Scale Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Large and Small-Scale Bioprocessing Market Scale Movement Analysis
4.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Scale, 2021 to 2033 (USD Million)
4.4. Industrial Scale (Over 50,000 Litre)
4.4.1. Industrial Scale (Over 50,000 Litre) market estimates and forecasts, 2021 to 2033 (USD Million)
4.5. Small Scale (Less Than 50,000 Litre)
4.5.1. Small Scale (Less Than 50,000 Litre) market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Large and Small-Scale Bioprocessing Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Large and Small-Scale Bioprocessing Market Product Movement Analysis
5.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
5.4. Bioreactors/Fermenters
5.4.1. Bioreactors/Fermenters market estimates and forecasts, 2021 to 2033 (USD Million)
5.5. Cell Culture Products
5.5.1. Cell Culture Products market estimates and forecasts, 2021 to 2033 (USD Million)
5.6. Bioreactors Accessories
5.6.1. Bioreactors Accessories market estimates and forecasts, 2021 to 2033 (USD Million)
5.7. Filtration Assemblies
5.7.1. Filtration Assemblies market estimates and forecasts, 2021 to 2033 (USD Million)
5.8. Bags & Containers
5.8.1. Bags & Containers market estimates and forecasts, 2021 to 2033 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. Large and Small-Scale Bioprocessing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Large and Small-Scale Bioprocessing Market Application Movement Analysis
6.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Biopharmaceuticals
6.4.1. Biopharmaceuticals market estimates and forecasts, 2021 to 2033 (USD Million)
6.5. Speciality Industrial Chemicals
6.5.1. Speciality Industrial Chemicals market estimates and forecasts, 2021 to 2033 (USD Million)
6.6. Environmental Aids
6.6.1. Environmental Aids market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 7. Large and Small-Scale Bioprocessing Market: Use Type Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Large and Small-Scale Bioprocessing Market Use Type Movement Analysis
7.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Use Type, 2021 to 2033 (USD Million)
7.4. Multi-Use
7.4.1. . Multi-Use market estimates and forecasts, 2021 to 2033 (USD Million)
7.5. . Single-Use
7.5.1. Single-Use market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 8. Large and Small-Scale Bioprocessing Market: Mode Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Large and Small-Scale Bioprocessing Market Mode Movement Analysis
8.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
8.4. . Biopharmaceuticals
8.4.1. Biopharmaceuticals market estimates and forecasts, 2021 to 2033 (USD Million)
8.5. Speciality Industrial Chemicals
8.5.1. Speciality Industrial Chemicals market estimates and forecasts, 2021 to 2033 (USD Million)
8.6. . In-House
8.6.1. In-House market estimates and forecasts, 2021 to 2033 (USD Million)
8.7. . Outsourced
8.7.1. Outsourced market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 9. Large and Small-Scale Bioprocessing Market: Workflow Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Global Large and Small-Scale Bioprocessing Market Workflow Movement Analysis
9.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
9.4. Downstream Processing
9.4.1. Downstream Processing market estimates and forecasts, 2021 to 2033 (USD Million)
9.5. Fermentation
9.5.1. Fermentation market estimates and forecasts, 2021 to 2033 (USD Million)
9.6. Upstream Processing
9.6.1. Upstream Processing market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 10. Large and Small-Scale Bioprocessing Market: Regional Estimates & Trend Analysis
10.1. Regional Market Share Analysis, 2024 & 2033
10.2. Regional Market Dashboard
10.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
10.4. North America
10.4.1. U.S.
10.4.1.1. Key country dynamics
10.4.1.2. Regulatory Framework
10.4.1.3. Competitive scenario
10.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
10.4.2. Canada
10.4.2.1. Key country dynamics
10.4.2.2. Regulatory Framework
10.4.2.3. Competitive scenario
10.4.3. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
10.4.4. Mexico
10.4.4.1. Key country dynamics
10.4.4.2. Competitive scenario
10.4.4.3. Regulatory Framework
10.4.4.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
10.5. Europe
10.5.1. UK
10.5.1.1. Key country dynamics
10.5.1.2. Competitive scenario
10.5.1.3. Regulatory Framework
10.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
10.5.2. Germany
10.5.2.1. Key country dynamics
10.5.2.2. Competitive scenario
10.5.2.3. Regulatory Framework
10.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
10.5.3. France
10.5.3.1. Key country dynamics
10.5.3.2. Competitive scenario
10.5.3.3. France market estimates and forecasts, 2021 to 2033 (USD Million)
10.5.4. Italy
10.5.4.1. Key country dynamics
10.5.4.2. Competitive scenario
10.5.4.3. Regulatory Framework
10.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
10.5.5. Spain
10.5.5.1. Key country dynamics
10.5.5.2. Competitive scenario
10.5.5.3. Regulatory Framework
10.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
10.5.6. Norway
10.5.6.1. Key country dynamics
10.5.6.2. Competitive scenario
10.5.6.3. Regulatory Framework
10.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
10.5.7. Sweden
10.5.7.1. Key country dynamics
10.5.7.2. Competitive scenario
10.5.7.3. Regulatory Framework
10.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
10.5.8. Denmark
10.5.8.1. Key country dynamics
10.5.8.2. Competitive scenario
10.5.8.3. Regulatory Framework
10.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
10.6. Asia Pacific
10.6.1. Japan
10.6.1.1. Key country dynamics
10.6.1.2. Competitive scenario
10.6.1.3. Regulatory Framework
10.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
10.6.2. China
10.6.2.1. Key country dynamics
10.6.2.2. Competitive scenario
10.6.2.3. Regulatory Framework
10.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
10.6.3. India
10.6.3.1. Key country dynamics
10.6.3.2. Competitive scenario
10.6.3.3. Regulatory Framework
10.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
10.6.4. Australia
10.6.4.1. Key country dynamics
10.6.4.2. Competitive scenario
10.6.4.3. Regulatory Framework
10.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
10.6.5. South Korea
10.6.5.1. Key country dynamics
10.6.5.2. Competitive scenario
10.6.5.3. Regulatory Framework
10.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
10.6.6. Thailand
10.6.6.1. Key country dynamics
10.6.6.2. Competitive scenario
10.6.6.3. Regulatory Framework
10.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
10.7. Latin America
10.7.1. Brazil
10.7.1.1. Key country dynamics
10.7.1.2. Competitive scenario
10.7.1.3. Regulatory Framework
10.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
10.7.2. Argentina
10.7.2.1. Key country dynamics
10.7.2.2. Competitive scenario
10.7.2.3. Regulatory Framework
10.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
10.8. MEA
10.8.1. South Africa
10.8.1.1. Key country dynamics
10.8.1.2. Competitive scenario
10.8.1.3. Regulatory Framework
10.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
10.8.2. Saudi Arabia
10.8.2.1. Key country dynamics
10.8.2.2. Competitive scenario
10.8.2.3. Regulatory Framework
10.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
10.8.3. UAE
10.8.3.1. Key country dynamics
10.8.3.2. Competitive scenario
10.8.3.3. Regulatory Framework
10.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
10.8.4. Kuwait
10.8.4.1. Key country dynamics
10.8.4.2. Competitive scenario
10.8.4.3. Regulatory Framework
10.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 11. Competitive Landscape
11.1. Company/Competition Categorization
11.2. Strategy Mapping
11.3. Company Market Position Analysis, 2024
11.4. Company Profiles/Listing
11.4.1. Merck KGaA
11.4.1.1. Company overview
11.4.1.2. Financial performance
11.4.1.3. Product benchmarking
11.4.1.4. Strategic initiatives
11.4.2. Thermo Fisher Scientific, Inc.
11.4.2.1. Company overview
11.4.2.2. Financial performance
11.4.2.3. Product benchmarking
11.4.2.4. Strategic initiatives
11.4.3. Danaher (Cytiva)
11.4.3.1. Company overview
11.4.3.2. Financial performance
11.4.3.3. Product benchmarking
11.4.3.4. Strategic initiatives
11.4.4. Corning Inc.
11.4.4.1. Company overview
11.4.4.2. Financial performance
11.4.4.3. Product benchmarking
11.4.4.4. Strategic initiatives
11.4.5. Sartorius AG
11.4.5.1. Company overview
11.4.5.2. Financial performance
11.4.5.3. Product benchmarking
11.4.5.4. Strategic initiatives
11.4.6. CESCO BIOENGINEERING CO., LTD
11.4.6.1. Company overview
11.4.6.2. Financial performance
11.4.6.3. Product benchmarking
11.4.6.4. Strategic initiatives
11.4.7. Bio-Process Group
11.4.7.1. Company overview
11.4.7.2. Financial performance
11.4.7.3. Product benchmarking
11.4.7.4. Strategic initiatives
11.4.8. BPC Instruments AB
11.4.8.1. Company overview
11.4.8.2. Financial performance
11.4.8.3. Product benchmarking
11.4.8.4. Strategic initiatives
11.4.9. Eppendorf AG
11.4.9.1. Company overview
11.4.9.2. Financial performance
11.4.9.3. Product benchmarking
11.4.9.4. Strategic initiatives
11.4.10. Getinge AB
11.4.10.1. Company overview
11.4.10.2. Financial performance
11.4.10.3. Product benchmarking
11.4.10.4. Strategic initiatives
11.4.11. Lonza
11.4.11.1. Company overview
11.4.11.2. Financial performance
11.4.11.3. Product benchmarking
11.4.11.4. Strategic initiatives
11.4.12. PBS Biotech, Inc
11.4.12.1. Company overview
11.4.12.2. Financial performance
11.4.12.3. Product benchmarking
11.4.12.4. Strategic initiatives
11.4.13. Bio-Synthesis, Inc.
11.4.13.1. Company overview
11.4.13.2. Financial performance
11.4.13.3. Product benchmarking
11.4.13.4. Strategic initiatives
11.4.14. Meissner Filtration Products, Inc.
11.4.14.1. Company overview
11.4.14.2. Financial performance
11.4.14.3. Product benchmarking
11.4.14.4. Strategic initiatives
11.4.15. Entegris
11.4.15.1. Company overview
11.4.15.2. Financial performance
11.4.15.3. Product benchmarking
11.4.15.4. Strategic initiatives
11.4.16. KUHNER AG
11.4.16.1. Company overview
11.4.16.2. Financial performance
11.4.16.3. Product benchmarking
11.4.16.4. Strategic initiatives
11.4.17. Saint-Gobain
11.4.17.1. Company overview
11.4.17.2. Financial performance
11.4.17.3. Product benchmarking
11.4.17.4. Strategic initiatives
11.4.18. ExcellGene SA
11.4.18.1. Company overview
11.4.18.2. Financial performance
11.4.18.3. Product benchmarking
11.4.18.4. Strategic initiatives
11.4.19. Repligen Corporation
11.4.19.1. Company overview
11.4.19.2. Financial performance
11.4.19.3. Product benchmarking
11.4.19.4. Strategic initiatives
11.4.20. Avantor, Inc
11.4.20.1. Company overview
11.4.20.2. Financial performance
11.4.20.3. Product benchmarking
11.4.20.4. Strategic initiatives
11.4.21. CerCell A/S
11.4.21.1. Company overview
11.4.21.2. Financial performance
11.4.21.3. Product benchmarking
11.4.21.4. Strategic initiatives
11.4.22. Univercells Technologies
11.4.22.1. Company overview
11.4.22.2. Financial performance
11.4.22.3. Product benchmarking
11.4.22.4. Strategic initiatives
11.4.23. Distek, Inc.
11.4.23.1. Company overview
11.4.23.2. Financial performance
11.4.23.3. Product benchmarking
11.4.23.4. Strategic initiatives
11.4.24. F. Hoffmann-La Roche Ltd
11.4.24.1. Company overview
11.4.24.2. Financial performance
11.4.24.3. Product benchmarking
11.4.24.4. Strategic initiatives